GleamWall
中文EN

CAH CARDINAL HEALTH INC

Wholesale-Drugs, Proprietaries & Druggists' Sundries · NYSE · SEC CIK 721371 · Fiscal year ends 06/30

Financial factors as of 2026-06-30 (FY2026), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY14.2%
TTM net income YoY9.8%
TTM EPS YoY12.1%
Revenue 3-yr CAGR7.4%
Net income 3-yr CAGR73.2%

Margins

Gross margin3.8%
Operating margin1.0%
Net margin0.7%
FCF margin1.8%
EBITDA margin1.4%

Returns

ROE—
ROA3.1%
ROIC (approx.)135.8%
Asset turnover4.61x

Leverage & solvency

Liabilities / assets104.8%
Debt / equity—
Current ratio0.88x
Interest coverage7.51x

Cash quality & payout

Operating cash flow / net income3.02x
Accruals ratio-6.3%
Payout ratio28.6%
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-06-30FY20252025-06-30
Income statement
Revenue$254.25B$222.58B
Cost of revenue$244.47B$214.41B
Gross profit$9.77B$8.17B
SG&A expense$6.13B$5.38B
Operating income$2.61B$2.27B
Interest expense$348.00M$215.00M
Pretax income$2.17B$2.10B
Income tax$469.00M$532.00M
Net income$1.71B$1.56B
EBITDA$3.57B$3.06B
EPS (basic)7.276.48
EPS (diluted)7.236.45
Dividends declared per share2.042.02
Weighted avg. shares (diluted)237.00M242.00M
Balance sheet
Cash & equivalents$4.86B$3.87B
Receivables$13.81B$13.24B
Inventory$17.30B$16.83B
Current assets$38.75B$36.37B
PP&E, net$3.03B$2.86B
Goodwill$11.44B$9.69B
Intangibles$2.19B$2.49B
Total assets$57.30B$53.12B
Current liabilities$43.90B$38.90B
Short-term debt$1.88B$550.00M
Long-term debt$7.00B$7.98B
Total debt$8.89B$8.53B
Total liabilities$60.02B$55.76B
Shareholders' equity-$2.88B-$2.78B
Net debt$4.03B$4.65B
Cash flow statement
Operating cash flow$5.17B$2.40B
Capital expenditure$649.00M$547.00M
Free cash flow$4.53B$1.85B
Investing cash flow-$2.58B-$5.59B
Financing cash flow-$1.60B$1.94B
Depreciation & amortization$956.00M$790.00M
Stock-based compensation$367.00M$244.00M
Dividends paid$491.00M$494.00M
Share buybacks$1.36B$765.00M

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.